Type 1 Diabetes Clinical Trial
Official title:
Determining the Appropriate Intensity of Vigorous Intensity Exercise to Prevent Post-exercise Hypoglycemia in Persons Living With Type 1 Diabetes
Over 300, 000 youth and young adults across Canada are living with Type 1 Diabetes (T1D)
which is considered the most common endocrine condition. Physical activity offers numerous
health benefits however the majority of persons living with T1D are physically inactive,
primarily due to fear of low blood sugar (hypoglycemia). This fear of hypoglycemia continues
to exist for physically active persons with T1D as no established physical activity
guidelines exist. Several acute studies have used high intensity interval training as a way
to reduce the risk of hypoglycemia as it has the ability to activate fight or flight hormones
which can raise blood sugar; however the intensity needed to elicit this response is unknown.
The purpose of this project is to determine the acute effects of varying exercise intensities
on the time spent in a low blood sugar range in 10 sedentary (VIGOR acute sedentary) and 16
physically active (VIGOR acute trained) individuals with T1D. Each participant will complete
a maximal exercise test prior to the exercise sessions. Sedentary participants will complete
45 minutes of continuous moderate intensity exercise at 45-55% heart rate reserve (HRR) and
three high intensity interval sessions with six one minute burst of high intensity at 70%,
80%, or 90% of HRR every four minutes. Active participants will complete 45 minutes of
moderate intensity exercise at 45-55% of HRR and one high intensity interval session at 90%
of HRR with intervals spaced every two minutes.
The investigators will track the blood sugar response to exercise using a device called a
continuous glucose monitor (CGM) which records blood sugar every five minutes over a period
of six days. The CGM will help determine which exercise intensity does a better job at
reducing the time spent in a low blood sugar range. The information gained through this study
will help individuals with T1D remain active without fear of low blood sugar and provide
guidelines for professionals working with this population.
Adding high intensity bursts at 80% and 90% of maximum aerobic capacity (active participants)
or heart rate reserve (sedentary participants) to a moderate intensity exercise session will
significantly reduce the amount of time spent in a low blood sugar range in sedentary and
active persons with T1D compared to moderate intensity exercise alone.
Sedentary Arm: This portion of the study is complete. 10 participants completed the study in
its entirety. Maximal exercise testing utilized a Parvomedics Metabolic cart to analyze
oxygen consumption in ml/kg/min and maximum heart rate. Results from this test were used to
estimate intensity using heart rate for the exercise sessions. Prior to each exercise
session, participants arrived at 4:00 PM ate a Glucerna bar (to prevent drastic falls in
glycemia with exercise) and had an IV inserted. A total of six blood samples were taken at
each session at the following timepoints: (1) 0 mins-baseline, (2) 10 mins- end of warm up,
(3) 35 mins-end of intervals, (4) 45 mins-end of exercise, (5) 75 mins-mid recovery, and (6)
105 mins-end of exercise. Each blood draw was sampled for glucose, cortisol, and growth
hormone. Before exercise, blood glucose was measured on a handheld glucometer. If blood
glucose was <5.7 mmol/L glucose was administered via Dex4 tablets. Exercise did not begin
until blood glucose was at least 5.7 mmol/L. If blood glucose was greater than 16.7 mmol/L
but less than 20.0 mmol/L ketones were tested on a urine ketone strip. If ketones were
negative or trace exercise began.
The first exercise session was 45 minutes of moderate intensity exercise at 45-55% of heart
rate reserve (HRR). The intensity determined from this session (speed and incline) was used
as the recovery intensity for the high intensity sessions. The high intensity sessions were
allocated in a random order from www.random.org where 1=70%, 2=80%, and 3=90%. Each high
intensity session started with 10 minutes of moderate intensity exercise (at the same speed
and incline from the first session) and six one minute bursts of high intensity every four
minutes followed by a 10 minute cool down.
Because of the small sample size and non-normal glucose profiles, data was analyzed using a
Friedman analysis of variance (non-parametric test).
Active Arm: This portion is still recruiting participants. The procedures for this experiment
are very similar to the sedentary component. Blood glucose targets prior to exercise are the
same however no blood samples will be taken. Participants will arrive at the lab for 4:30 PM
and eat a Glucerna bar (to avoid drastic falls in glycemia with exercise). The two exercise
sessions, moderate and 90%, will be allocated in a random order from a coin flip where heads
is moderate exercise and tails is the 90% intervals. The moderate intensity session will
consist of 45 minutes of exercise at 45-55% of HRR. The 90% session will consist of 15
minutes of moderate intensity at 45-55% of HRR followed by six one minute bursts of exercise
at 90% of HRR every two minutes followed by a 10 minute cooldown.
Data will be analyzed using a general linear model and logistic regression.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02750527 -
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
|